Table 1 Population characteristics: Baseline and follow-up (N = 601,331)
Characteristics | N (%) |
|---|---|
Female Sex | 294,490 (49) |
Age group | |
18–44 | 49,362 (8.2) |
45–64 | 217,229 (36.1) |
65+ | 334,740 (55.7) |
Rural residency | 85,547 (14.2) |
Region | |
Central | 190,015 (31.6) |
Central east | 94,127 (15.7) |
East | 83,660 (13.9) |
North | 45,937 (7.6) |
South | 104,718 (17.4) |
Southwest | 82,592 (13.7) |
Cancer type | |
Brain and Other Nervous System | 8553 (1.4) |
Breast | 81,553 (13.6) |
Cervix Uteri | 5197 (0.9) |
Colon and Rectum | 71,754 (11.9) |
Digestive System, except Colon | 49,621 (8.3) |
Endocrine System | 22,564 (3.8) |
Female Genital System, except | 30,983 (5.2) |
Leukemia | 16,996 (2.8) |
Lung and Bronchus | 75,619 (12.6) |
Lymphoma | 28,437 (4.7) |
Myeloma | 8487 (1.4) |
Oral Cavity and Pharynx | 13,715 (2.3) |
Other | 39,691 (6.6) |
Prostate | 87,377 (14.5) |
Skin excluding Basal and Squam | 23,952 (4) |
Urinary System | 36,832 (6.1) |
Stage of cancer | |
1 | 80,182 (13.3) |
2 | 103,148 (17.2) |
3 | 61,109 (10.2) |
4 | 69,693 (11.6) |
unknown | 287,199 (47.8) |
Multimorbidity | |
No additional condition | 52,083 (8.7) |
1 | 97,478 (16.2) |
2 | 118,310 (19.7) |
3 | 109,166 (18.2) |
4 | 85,077 (14.1) |
5 or more conditions | 139,217 (23.2) |
Follow-up in years: Average (SD); range | 5.8 (4.5); 0a - 15 |
Health service use within the first year (follow-up > =30 daysb) | |
Primary care visit: at least one | 519,752 (92.2) |
Primary care visit: High use (90th pct, i.e. > = 15) | 63,835 (11.4) |
ED visit: at least one | 228,280 (40.7) |
ED visit: High use (90th pct, i.e. > 3) | 57,239 (10.2) |
Hospital admission: at least one | 325,513 (58.1) |
Hospital admission: High use (90th pct, i.e. > = 2) | 127,976 (22.8) |
Mortality (follow-up > =30 days) | |
Within first year | 107,378 (19.2) |
Within five years | 219,315 (39.1) |
Overall, during follow-up | 281,268 (49.8) |